In a case report, we documented the curious notion that 2 individuals treated with the glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) liraglutide for obesity and type 2 diabetes, respectively, experienced remarkable improvement of concomitant BAD symptoms (15)
Possible side effects of orlistat (Xenical/Alli) While the active ingredient orlistat which works by inhibiting the enzymes that break down fat in the gut, preventing your body from absorbing it debuted back in 1999 to a lot of fanfare, Fishman says its become less popular for two big reasons: side effects and minimal benefits. Those side effects are mostly gastrointestinal, and can include abdominal pain in up to 30% of patients
GLP-1 therapies are shaking up the world of diabetes and obesity care, opening new doors for both patients and pharmaceutical companies
She helped me see that success wasnt just about eating less, but about fueling my body with the right nutrients, especially protein
103rd Avenue Suite 60, Sun City, AZ 85351
Pharmacokinetics and safety of Iglarlixi in healthy chinese participants: Results of a phase 1 randomized study